Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma

P. Rampini, C. Occella, D. Bleidl, E. Rampini

Research output: Contribution to journalArticle

Abstract

On the basis of recent reports on the effects of interferon on hemangiomas we used interferon alfa-2b therapy in a three month old child with extensive vision threatening facial hemangioma refractory to systemic corticosteroids. After nine months of therapy with interferon the hemangioma regressed almost completely. No regrowth has been observed after a follow-up of 13 months.

Original languageEnglish
Pages (from-to)502-504
Number of pages3
JournalNouvelles Dermatologiques
Volume14
Issue number8
Publication statusPublished - 1995

Fingerprint

interferon alfa-2b
Hemangioma
Interferons
Adrenal Cortex Hormones
Therapeutics

Keywords

  • hemangioma
  • interferon alfa-2b

ASJC Scopus subject areas

  • Dermatology

Cite this

Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma. / Rampini, P.; Occella, C.; Bleidl, D.; Rampini, E.

In: Nouvelles Dermatologiques, Vol. 14, No. 8, 1995, p. 502-504.

Research output: Contribution to journalArticle

Rampini, P. ; Occella, C. ; Bleidl, D. ; Rampini, E. / Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma. In: Nouvelles Dermatologiques. 1995 ; Vol. 14, No. 8. pp. 502-504.
@article{edd371610832428bb9098e248eb0c499,
title = "Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma",
abstract = "On the basis of recent reports on the effects of interferon on hemangiomas we used interferon alfa-2b therapy in a three month old child with extensive vision threatening facial hemangioma refractory to systemic corticosteroids. After nine months of therapy with interferon the hemangioma regressed almost completely. No regrowth has been observed after a follow-up of 13 months.",
keywords = "hemangioma, interferon alfa-2b",
author = "P. Rampini and C. Occella and D. Bleidl and E. Rampini",
year = "1995",
language = "English",
volume = "14",
pages = "502--504",
journal = "Nouvelles Dermatologiques",
issn = "0752-5370",
publisher = "Les Nouvelles Dermatologiques",
number = "8",

}

TY - JOUR

T1 - Interferon alfa-2b therapy for extensive vision-threatening facial hemangioma

AU - Rampini, P.

AU - Occella, C.

AU - Bleidl, D.

AU - Rampini, E.

PY - 1995

Y1 - 1995

N2 - On the basis of recent reports on the effects of interferon on hemangiomas we used interferon alfa-2b therapy in a three month old child with extensive vision threatening facial hemangioma refractory to systemic corticosteroids. After nine months of therapy with interferon the hemangioma regressed almost completely. No regrowth has been observed after a follow-up of 13 months.

AB - On the basis of recent reports on the effects of interferon on hemangiomas we used interferon alfa-2b therapy in a three month old child with extensive vision threatening facial hemangioma refractory to systemic corticosteroids. After nine months of therapy with interferon the hemangioma regressed almost completely. No regrowth has been observed after a follow-up of 13 months.

KW - hemangioma

KW - interferon alfa-2b

UR - http://www.scopus.com/inward/record.url?scp=0028839527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028839527&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 502

EP - 504

JO - Nouvelles Dermatologiques

JF - Nouvelles Dermatologiques

SN - 0752-5370

IS - 8

ER -